FILE:BMY/BMY-8K-20080922214009.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
 
 
 
 
 
Item 8.01.  Other Events.
 
On September 22, 2008, Bristol-Myers Squibb Company (the Company) issued a press release announcing its intention to commence a tender offer for all the outstanding shares of ImClone Systems Incorporated (ImClone) and to launch a consent solicitation seeking to remove each member of the Board of Directors of ImClone and replace them with five nominees proposed by the Company.  This was communicated to the Board of Directors of ImClone in a letter dated September 22, 2008.  The press release, including the full text of the letter delivered to the Board of Directors of ImClone, is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
 
Item 9.01.  Financial Statements and Exhibits.
(d)           Exhibits.
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 

 
Exhibit 99.1
 
 


